|
summary: This study on 146 people with secondary progressive MS found that patients with two or more relapses in the two years before starting treatment with interferon beta experienced a higher risk of clinical deterioration over time.
authors: Rio J, Tintore M, Nos C, Tellez N, Galan I, Pelayo R, Montalban X.
source: J Neurol. 2007 Mar 14
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Interferon
Multiple sclerosis
Relapse
Sclerosis
Secondary progressive multiple sclerosis
|
